全文获取类型
收费全文 | 8350篇 |
免费 | 710篇 |
国内免费 | 129篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 251篇 |
妇产科学 | 130篇 |
基础医学 | 1082篇 |
口腔科学 | 237篇 |
临床医学 | 788篇 |
内科学 | 1858篇 |
皮肤病学 | 193篇 |
神经病学 | 650篇 |
特种医学 | 552篇 |
外国民族医学 | 2篇 |
外科学 | 1091篇 |
综合类 | 78篇 |
预防医学 | 558篇 |
眼科学 | 165篇 |
药学 | 556篇 |
中国医学 | 25篇 |
肿瘤学 | 862篇 |
出版年
2023年 | 34篇 |
2022年 | 32篇 |
2021年 | 175篇 |
2020年 | 121篇 |
2019年 | 244篇 |
2018年 | 275篇 |
2017年 | 180篇 |
2016年 | 207篇 |
2015年 | 242篇 |
2014年 | 294篇 |
2013年 | 366篇 |
2012年 | 431篇 |
2011年 | 477篇 |
2010年 | 311篇 |
2009年 | 279篇 |
2008年 | 393篇 |
2007年 | 418篇 |
2006年 | 355篇 |
2005年 | 382篇 |
2004年 | 309篇 |
2003年 | 281篇 |
2002年 | 253篇 |
2001年 | 206篇 |
2000年 | 248篇 |
1999年 | 188篇 |
1998年 | 153篇 |
1997年 | 148篇 |
1996年 | 142篇 |
1995年 | 111篇 |
1994年 | 108篇 |
1993年 | 116篇 |
1992年 | 124篇 |
1991年 | 151篇 |
1990年 | 131篇 |
1989年 | 167篇 |
1988年 | 112篇 |
1987年 | 135篇 |
1986年 | 97篇 |
1985年 | 100篇 |
1984年 | 79篇 |
1983年 | 45篇 |
1982年 | 60篇 |
1981年 | 57篇 |
1980年 | 56篇 |
1979年 | 53篇 |
1978年 | 29篇 |
1977年 | 48篇 |
1976年 | 58篇 |
1975年 | 33篇 |
1971年 | 27篇 |
排序方式: 共有9189条查询结果,搜索用时 31 毫秒
1.
Leonie Konczalla Daniel R. Perez Nadine Wenzel Gerrit Wolters-Eisfeld Clarissa Klemp Johanna Lüddeke Annika Wolski Dirk Landschulze Chris Meier Anika Buchholz Dichao Yao Bianca T. Hofmann Julia K. Graß Sarah L. Spriestersbach Katharina Grupp Udo Schumacher Christian Betzel Svetlana Kapis Theresa Nuguid Pablo Steinberg Klaus Püschel Guido Sauter Maximillian Bockhorn Faik G. Uzunoglu Jakob R. Izbicki Cenap Güngör Alexander T. El Gammal 《International journal of cancer. Journal international du cancer》2020,146(6):1618-1630
MALT1 is a key mediator of NF-κB signaling and a main driver of B-cell lymphomas. Remarkably, MALT1 is expressed in the majority of pancreatic ductal adenocarcinomas (PDACs) as well, but absent from normal exocrine pancreatic tissue. Following, MALT1 shows off to be a specific target in cancer cells of PDAC without affecting regular pancreatic cells. Therefore, we studied the impact of pharmacological MALT1 inhibition in pancreatic cancer and showed promising effects on tumor progression. Mepazine (Mep), a phenothiazine derivative, is a known potent MALT1 inhibitor. Newly, we described that biperiden (Bip) is a potent MALT1 inhibitor with even less pharmacological side effects. Thus, Bip is a promising drug leading to reduced proliferation and increased apoptosis in PDAC cells in vitro and in vivo. By compromising MALT1 activity, nuclear translocation of c-Rel is prevented. c-Rel is critical for NF-κB-dependent inhibition of apoptosis. Hence, off-label use of Bip or Mep represents a promising new therapeutic approach to PDAC treatment. Regularly, the Anticholinergicum Bip is used to treat neurological side effects of Phenothiazines, like extrapyramidal symptoms. 相似文献
2.
Christopher L. Heidler Eva K. Roth Markus Thiemann Claudia Blattmann Ramon L. Perez Peter E. Huber Michal Kovac Beate Amthor Gabriele Neu-Yilik Andreas E. Kulozik 《International journal of cancer. Journal international du cancer》2020,147(4):1059-1070
Progress in the systemic control of osteosarcoma has been limited over the past decades thus indicating the urgent clinical need for the development of novel treatment strategies. Therefore, we have recently developed new preclinical models to study promising novel agents for the treatment of pediatric osteosarcoma. The checkpoint kinase (chk) inhibitor prexasertib (LY2606368) and its salt form (LSN2940930) have recently been shown to be active in adult and pediatric malignancies, including sarcoma. We have now tested the potency of prexasertib in clonogenic survival assays in two new lines of primary patient-derived osteosarcoma cells and in two established osteosarcoma cell lines as a single agent and in combination with cisplatin and the poly ADP-ribose polymerase (PARP) inhibitor talazoparib. Prexasertib alone results in strongly reduced clonogenic survival at low nanomolar concentrations and acts by affecting cell cycle progression, induction of apoptosis and induction of double-stranded DNA breakage at concentrations that are well below clinically tolerable and safe plasma concentrations. In combination with cisplatin and talazoparib, prexasertib acts in a synergistic fashion. Chk1 inhibition by prexasertib and its combination with the DNA damaging agent cisplatin and the PARP-inhibitor talazoparib thus emerges as a potential new treatment option for pediatric osteosarcoma which will now have to be tested in preclinical primary patient derived in vivo models and clinical studies. 相似文献
3.
4.
5.
6.
Rachel A. Schambow Fernando Sampedro Pedro E. Urriola Jennifer L. G. van de Ligt Andres Perez Gerald C. Shurson 《Transboundary and Emerging Diseases》2022,69(1):157-175
Economically relevant pathogens, such as African swine fever virus (ASFV), have been shown to survive when experimentally inoculated in some feed ingredients under the environmental conditions in transoceanic transport models. However, these models did not characterize the likelihood of virus survival under various time and temperature processes that feed ingredients undergo before they are added to swine diets. Here, we developed a quantitative risk assessment model to estimate the probability that one or more corn or soybean meal ocean vessels (25,000 tonnes) contaminated with ASFV would be imported into the United States annually. This final probability estimate was conditionally based on five likelihoods: the probability of initial ASFV contamination (p0), ASFV inactivation during processing (p1) and transport (p2), recontamination (pR), and ASFV inactivation while awaiting customs clearance at United States entry (p3). The probability of ASFV inactivation was modelled using corn and soybean (extruded or solvent extracted) processing conditions (times and temperatures), D-values (time to reduce 90% or 1-log) estimated from studies of ASFV thermal inactivation in pork serum (p1), and survival in feed ingredients during transoceanic transport (p2 and p3). ‘What-if’ scenarios using deterministic values for p0 and pR (1%, 10%, 25%, 50%, 75%, and 100%) were used to explore their impact on risk. The model estimated complete inactivation of ASFV after extrusion or solvent extraction processes regardless of the initial ASFV contamination probability assumed. The value of recontamination (ranging from 1% to 75%) was highly influential on the risk of one ASFV-contaminated soybean meal vessel entering the United States. Median risk estimates ranged from 0.064% [0.006%–0.60%; 95% probability interval (PI)], assuming a pR of 1.0%, up to 4.67% (0.45%–36.50% 95% PI) assuming a pR of 75.0%. This means that at least one vessel with ASFV-contaminated soybean meal would be imported once every 1563–21 years, respectively. When all raw corn was assumed to be contaminated (p0 = 100%), and no recontamination was assumed to occur (pR = 0%), the median probability of one vessel with ASFV-contaminated corn entering the United States was 2.02% (0.28%–9.43% 95% PI) or once every 50 years. Values of recontamination between 1% and 75% did not substantially change the risk of corn. Days of transport, virus survival during transport (D-value), and number of vessels shipped were the parameters most influential for increased likelihood of a vessel with ASFV-contaminated soybean meal or corn entering the United States. The model helped to identify knowledge gaps that are most influential on output values and serves as a framework that could be updated and parameterized as new scientific information becomes available. We propose that the quantitative risk assessment model developed in this study can be used as a framework for estimating the risk of ASFV entry into the United States and other ASFV-free countries through other types of imported feed ingredients that may potentially become contaminated. Ultimately, this model can be used to develop risk mitigation strategies and critical control points for inactivating ASFV during feed ingredient processing, storage, and transport, and contribute to the design and implementation of biosecurity measures to prevent the introduction of ASFV into the United States and other ASFV-free countries. 相似文献
7.
Jasmine Martinez Christine Liu Nyah Rodman Jennifer S. Fernandez Claudia Barberis Rodrigo Sieira Federico Perez Robert A. Bonomo Maria Soledad Ramirez 《Diagnostic microbiology and infectious disease》2019,93(3):183-187
Transformation is one of the mechanisms of acquisition of foreign genetic material leading to the emergence of multidrug resistant (MDR) bacteria. Recently, human serum albumin (HSA) was shown to specifically increase transformation frequency in the nosocomial pathogen Acinetobacter baumannii. To further assess the relevance of HSA as a possible modulator of A. baumannii transformation in host-pathogen interactions, in this work we examined the effect of different human fluids. We observed a significant increase in transformation frequencies in the presence of pleural fluid, whole blood cells and liquid ascites, and to a lesser extent with urine. The observed effects correlate with both HSA and bacterial content found in the assayed patient fluids. Taken together, these results are in agreement with our previous findings that highlight HSA as a possible host signal with the ability to trigger natural transformation in A. baumannii. 相似文献
8.
Tracy Anton Mark S. Sklansky Mishella Perez Dolores H. Pretorius 《Journal of ultrasound in medicine》2019,38(12):3335-3347
In 2018, the American Institute of Ultrasound in Medicine revised its obstetric Practice Parameter for the second‐trimester fetal anatomic survey. The 2018 Practice Parameter recommends incorporation of the 3‐vessel view and 3‐vessel and trachea view “if technically feasible.” Sonographers and other medical providers may require additional training and education to develop greater proficiency in obtaining and interpreting these views. This pictorial essay, including ultrasound images alongside their respective schematic diagrams, provides an up‐to‐date, practical, and clinically oriented review of the 3‐vessel view and 3‐vessel and trachea view and their most common presentations in the context of congenital heart disease. 相似文献
9.
10.
Marcelina G. Perez Magali Fassiotto Jonathan Altamirano Gloria L. Hwang Yvonne Maldonado Shellie Josephs Daniel Y. Sze Nishita Kothary 《Journal of vascular and interventional radiology : JVIR》2019,30(4):579-583